رجوع
42
48
مُدرج أيضًا باسم
CHJTF
OTC
نطاق اليوم
KWD 4.36
KWD 4.41
نطاق 52 أسبوعًا
KWD 2.32
KWD 5.83
حجم التداول
1
متوسط 50 يوم / 200 يوم
KWD 4.90
/
KWD 4.61
الإغلاق السابق
KWD 4.51
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 2.8 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 14.1 | 3.7 |
| Net Margin % | 14.9 | 3.9 |
| Rev Growth 5Y % | 1.0 | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2026 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
270 B | 0 |
النقاط الرئيسية
Revenue grew 1.04% annually over 5 years — modest growth
Earnings declined -21.59% over the past year
ROE of 14.07% — decent returns on equity
Debt/Equity of 0.02 — conservative balance sheet
Generating 1.86B in free cash flow
P/E of 2.77 — trading at a low valuation
النمو
Revenue Growth (5Y)
1.04%
Revenue (1Y)-10.78%
Earnings (1Y)-21.59%
FCF Growth (3Y)-38.49%
الجودة
Return on Equity
14.07%
ROIC13.07%
Net Margin14.92%
Op. Margin18.50%
الأمان
Debt / Equity
0.02
Current Ratio2.27
Interest Coverage130.74
التقييم
P/E Ratio
2.77
P/B Ratio0.40
EV/EBITDA1.14
Dividend Yield0.06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -10.78% | Revenue Growth (3Y) | -6.10% |
| Earnings Growth (1Y) | -21.59% | Earnings Growth (3Y) | -18.27% |
| Revenue Growth (5Y) | 1.04% | Earnings Growth (5Y) | -2.80% |
| Profitability | |||
| Revenue (TTM) | 30.87B | Net Income (TTM) | 4.61B |
| ROE | 14.07% | ROA | 10.37% |
| Gross Margin | 69.97% | Operating Margin | 18.50% |
| Net Margin | 14.92% | Free Cash Flow (TTM) | 1.86B |
| ROIC | 13.07% | FCF Growth (3Y) | -38.49% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 2.27 |
| Interest Coverage | 130.74 | Dividend Yield | 0.06% |
| Valuation | |||
| P/E Ratio | 2.77 | P/B Ratio | 0.40 |
| P/S Ratio | 0.41 | PEG Ratio | -0.53 |
| EV/EBITDA | 1.14 | Dividend Yield | 0.06% |
| Market Cap | 12.75B | Enterprise Value | 6.48B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 30.87B | 34.60B | 35.01B | 34.19B | 29.62B |
| Net Income | 4.61B | 5.87B | 6.89B | 6.88B | 5.16B |
| EPS (Diluted) | 1.56 | 2.00 | 2.04 | 1.88 | 2.04 |
| Gross Profit | 21.60B | 24.40B | 22.73B | 25.47B | 21.00B |
| Operating Income | 5.71B | 7.68B | 7.58B | 7.66B | 6.49B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 44.39B | 46.28B | 41.77B | 42.50B | 35.65B |
| Total Liabilities | 10.52B | 12.39B | 11.46B | 9.71B | 8.28B |
| Shareholders' Equity | 32.26B | 33.20B | 29.77B | 31.79B | 26.48B |
| Total Debt | 507.33M | 706.90M | 621.48M | 102.76M | 358.71M |
| Cash & Equivalents | 6.78B | 12.02B | 11.65B | 9.28B | 8.65B |
| Current Assets | 21.89B | 26.74B | 23.96B | 20.34B | 18.88B |
| Current Liabilities | 9.63B | 10.18B | 10.14B | 8.84B | 7.47B |
درجات الاستراتيجيات
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#409 of 820
#150 of 708
النشاط الأخير
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026